<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010035615">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Eftekhari, M.H.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Simondon, Kirsten</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Jalali, M.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Keshavarz, S.A.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Elguero, Eric</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Eshraghian, M.R.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Saadat, N.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Effects of administration of iron, iodine and simultaneous iron-plus-iodine on the thyroid hormone profile in iron-deficient adolescent Iranian girls</title>
        <secondary-title>European Journal of Clinical Nutrition</secondary-title>
      </titles>
      <pages>545-552</pages>
      <keywords>
        <keyword>FER</keyword>
        <keyword>ANEMIE</keyword>
        <keyword>DEFICIENCE</keyword>
        <keyword>SUPPLEMENTATION</keyword>
        <keyword>HORMONE</keyword>
        <keyword>ADOLESCENT</keyword>
        <keyword>CONSOMMATION ALIMENTAIRE</keyword>
        <keyword>ANALYSE STATISTIQUE</keyword>
        <keyword>ETUDE COMPARATIVE</keyword>
        <keyword>IODE</keyword>
        <keyword>FERRITINE</keyword>
        <keyword>GLANDE THYROIDE</keyword>
        <keyword>SULFATE DE FER</keyword>
        <keyword>iron</keyword>
        <keyword>ferritin</keyword>
        <keyword>thyroid hormones</keyword>
        <keyword>supplementation trial</keyword>
        <keyword>micronutrients</keyword>
        <keyword>IRAN</keyword>
      </keywords>
      <dates>
        <year>2006</year>
      </dates>
      <call-num>fdi:010035615</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>European Journal of Clinical Nutrition</full-title>
      </periodical>
      <isbn>0954-3007</isbn>
      <accession-num>CC:0002365301-0013</accession-num>
      <number>4</number>
      <electronic-resource-num>10.1038/sj.ejcn.1602349</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010035615</url>
        </related-urls>
        <pdf-urls>
          <url>https://www.documentation.ird.fr/intranet/publi/2006/05/010035615.pdf</url>
        </pdf-urls>
      </urls>
      <volume>60</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Objective: To investigate whether iron supplementation can improve thyroid hormone function in iron-deficient adolescent girls. Design: A double-blind randomized intervention study. Setting: The study was performed from 2002 through 2003 in the Islamic Republic of Iran. Subjects: 103 iron-deficient non-anaemic girls who fulfilled all inclusion criteria were included, and 94 subjects successfully completed the study. Interventions: Patients were randomly assigned to one of four groups and treated with a single oral dose of 190 mg iodine plus 300 mg ferrous sulphate 5 times/week (n = 24), 300 mg ferrous sulphate 5 times/week (n = 23), a single oral dose of 190 mg iodine ( n 25), or a placebo ( n 22) for 12 weeks. Results: All groups were comparable at baseline. After the intervention, there was a significant increase in ferritin and transferrin saturation in the iron + iodine group (17.6 vs 8.7 mu g/dl, and 18.8 vs 7.2%, respectively, P&lt;0.001 for both) and in the iron group (P&lt;0.001 for both). Urinary iodine doubled in the iron + iodine group and in the iodine group ( P&lt;0.001 for both). Thyroid indices tT4, tT3 and T3RU increased and reverse RT3 decreased in the iron + iodine group ( 10 vs 8.9 mu g/dl, P&lt; 0.001; 143 vs 138 mu g/dl, P&lt;0.05; 32.3 vs 28.4%, P&lt;0.001 and 24.8 vs 44.2 ng/dl, P&lt;0.001, respectively) and in the iron group. These two groups did not differ for any of the four indices, but both differed significantly from the iodine and placebo groups. Conclusions: Our results indicate that improvement of iron status was accompanied by an improvement in some indices of thyroid hormones.</abstract>
      <custom6>054PHYMED02</custom6>
    </record>
  </records>
</xml>
